Eli Lilly partners with AI-focused Genetic Leap to develop RNA-based drugs

Go back to Eli Lilly partners with AI-focused Genetic Leap to develop RNA-based drugs
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1149.66 -7.42 (0.64%)
Previous Close $1157.08    52 Week High $88.16 
Open $1155.00    52 Week Low $67.88 
Day High $1158.72    P/E 266.13 
Day Low $1141.50    EPS $4.32 
Volume 516,367